Citrullination Inactivates Nicotinamide- N-methyltransferase.
Venkatesh V NemmaraRonak TilvawalaAri J SalingerLacey MillerSon Hong NguyenEranthie WeerapanaPaul R ThompsonPublished in: ACS chemical biology (2018)
Nicotinamide- N-methyltransferase (NNMT) catalyzes the irreversible methylation of nicotinamide (NAM) to form N-methyl nicotinamide using S-adenosyl methionine as a methyl donor. NNMT is implicated in several chronic disease conditions, including cancers, kidney disease, cardiovascular disease, and Parkinson's disease. Although phosphorylation of NNMT in gastric tumors is reported, the functional effects of this post-translational modification has not been investigated. We previously reported that citrullination of NNMT by Protein Arginine Deiminases abolished its methyltransferase activity. Herein, we investigate the mechanism of inactivation. Using tandem mass spectrometry, we identified three sites of citrullination in NNMT. With this information in hand, we used a combination of site-directed mutagenesis, kinetics, and circular dichoism experiments to demonstrate that citrullination of R132 leads to a structural perturbation that ultimately promotes NNMT inactivation.
Keyphrases
- tandem mass spectrometry
- cardiovascular disease
- ultra high performance liquid chromatography
- liquid chromatography
- high performance liquid chromatography
- gas chromatography
- dna methylation
- crispr cas
- nitric oxide
- high resolution
- genome wide
- healthcare
- mass spectrometry
- small molecule
- high resolution mass spectrometry
- atomic force microscopy
- cardiovascular risk factors
- young adults